Synthetic Retinoids for Use in RAR Mediated Conditions

Andrew Whiting; David  Chisholm; Roy Valentine; Iain Robert Greig; Peter John Andrew McCaffery; Thabat Alkhatib

Synthetic Retinoids for Use in RAR Mediated Conditions

Andrew Whiting (Inventor), David Chisholm (Inventor), Roy Valentine (Inventor), Iain Robert Greig (Inventor), Peter John Andrew McCaffery (Inventor), Thabat Alkhatib (Inventor)

Medical Sciences

Research output: Patent

Abstract

There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

Original language	English
Patent number	WO2017174999
IPC	C07C 63/66,A61K 31/192,A61K 31/203,A61P 25/28,C07D 209/82,C07D 215/06
Priority date	6/04/17
Publication status	Published - 18 Apr 2019

Cite this

@misc{afd6bc0e7a1a423ea0b564aaa80f6669,

title = "Synthetic Retinoids for Use in RAR Mediated Conditions",

abstract = "There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.",

author = "Andrew Whiting and David Chisholm and Roy Valentine and Greig, {Iain Robert} and McCaffery, {Peter John Andrew} and Thabat Alkhatib",

year = "2019",

month = apr,

day = "18",

language = "English",

publisher = "European Patent Office",

type = "Patent",

note = "WO2017174999; C07C 63/66,A61K 31/192,A61K 31/203,A61P 25/28,C07D 209/82,C07D 215/06",

}

TY - PAT

T1 - Synthetic Retinoids for Use in RAR Mediated Conditions

AU - Whiting, Andrew

AU - Chisholm, David

AU - Valentine, Roy

AU - Greig, Iain Robert

AU - McCaffery, Peter John Andrew

AU - Alkhatib, Thabat

PY - 2019/4/18

Y1 - 2019/4/18

N2 - There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

AB - There are described novel compounds of formula I: in which R1, R2, R3, R4, R5, X1 and X2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition: and methods related thereto.

M3 - Patent

M1 - WO2017174999

PB - European Patent Office

ER -

Synthetic Retinoids for Use in RAR Mediated Conditions

Abstract

Fingerprint

Cite this